Title:
Development of new synthetic process for lenalidomide and novel formulations for sustained release tablet
Agreement Value:
$500,000.00
Agreement Date:
Nov 1, 2017 - Feb 29, 2020
Description:
This collaborative project between AC Pharmaceuticals Co., Ltd. in the city of Guangzhou, Guangdong Province, China and TC Scientific Inc. in Edmonton, Alberta, Canada, is to develop lenalidomide sustained-release tablets for the treatment of myelodysplastic syndromes (MDS). TC Scientific Inc. will develop new synthetic routes for lenalidomide and a production process that will be substantially less expensive to execute. The new process will avoid use of strong oxidizing agents and expensive reagents and will also reduce the generation of toxic waste by using less toxic reagents. Consequently, the overall production process will be more environmentally friendly. AC Pharmaceuticals Co., Ltd will develop lenalidomide sustained-release tablets with high bioavailability.
Organization:
National Research Council Canada
Expected Results:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Location:
Edmonton, Alberta, CA T6E 5V2
Reference Number:
GC-2017-Q3-33002
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
858041866
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 121 days.
Amendment Date
Oct 29, 2019
Recipient's Legal Name:
TC Scientific Inc.
Federal Riding Name:
Edmonton Mill Woods
Federal Riding Number:
48017
Program:
Canadian International Innovation Program
Program Purpose:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Coverage:
The Canadian International Innovation Program supports industrial R & D partnerships and matchmaking activities between Canadian companies and foreign partners with a view to accelerating commercialization and facilitating market access.